Fortrea to Participate in September Investor Conferences
Fortrea leadership will engage investors at three September 2026 healthcare conferences, including a webcast fireside chat at the Baird event.
Rhea-AI Summary
Fortrea (FTRE) will participate in three investor conferences in September 2026, featuring CEO Anshul Thakral, CFO Jason Knoblauch and SVP of Investor Relations Tracy Krumme.
Management will join a fireside chat and hold 1x1 and group meetings at the Baird 2026 Global Healthcare Conference in New York on September 15, 2026, from 2:00–2:30 p.m. EDT, with a live webcast and replay available via Fortrea’s Investor Relations “Events” page. They will also conduct 1x1 and group meetings at the Deutsche Bank 2026 Healthcare Summit in New York on September 16, 2026, and at the virtual RBC Pharma Services and Life Science Tools Conference on September 22, 2026. Investors seeking meetings are directed to contact their banking representatives.
Positive
- None.
Negative
- None.
Key Terms
cro technical
clinical pharmacology medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations, Tracy Krumme will participate in the following conferences in September:
Baird 2026 Global Healthcare Conference (NYC)
Date: Tuesday, September 15, 2026
Format: Fireside Chat & 1x1 and Group Meetings
Time: 2:00 -2:30 PM EDT
Webcast: FTRE Baird Webcast
Deutsche Bank 2026 Healthcare Summit (NYC)
Date: Wednesday, September 16, 2026
Format: 1x1 and Group Meetings
RBC Pharma Services and Life Science Tools Virtual Conference
Date: Tuesday, September 22, 2026
Format: 1x1 and Group Meetings
The live webcast and replay of the Baird fireside chat will be accessible through the “Events” section of Fortrea’s Investor Relations website. Investors interested in meeting with management should contact their banking representatives.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
How can investors access the Fortrea fireside chat at the Baird 2026 Global Healthcare Conference?
The live webcast and replay of Fortrea’s fireside chat at the Baird 2026 Global Healthcare Conference will be available through the “Events” section of the company’s Investor Relations website.
How can investors request 1x1 or group meetings with Fortrea management at these conferences?
Investors who are interested in meeting with Fortrea’s management at the Baird, Deutsche Bank or RBC conferences are instructed to contact their banking representatives.